911 related articles for article (PubMed ID: 18674567)
1. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
Murthy HM; Judge K; DeLucas L; Padmanabhan R
J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
[TBL] [Abstract][Full Text] [Related]
3. Identification and enzymatic characterization of NS2B-NS3 protease of Alkhurma virus, a class-4 flavivirus.
Bessaud M; Grard G; Peyrefitte CN; Pastorino B; Rolland D; Charrel RN; de Lamballerie X; Tolou HJ
Virus Res; 2005 Jan; 107(1):57-62. PubMed ID: 15567034
[TBL] [Abstract][Full Text] [Related]
4. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.
Luo D; Vasudevan SG; Lescar J
Antiviral Res; 2015 Jun; 118():148-58. PubMed ID: 25842996
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
6. Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.
Arias CF; Preugschat F; Strauss JH
Virology; 1993 Apr; 193(2):888-99. PubMed ID: 8460492
[TBL] [Abstract][Full Text] [Related]
7. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A.
Yamashita T; Unno H; Mori Y; Tani H; Moriishi K; Takamizawa A; Agoh M; Tsukihara T; Matsuura Y
Virology; 2008 Apr; 373(2):426-36. PubMed ID: 18201743
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the domain interactions between the protease and helicase of NS3 in dengue and hepatitis C virus.
Rosales-León L; Ortega-Lule G; Ruiz-Ordaz B
J Mol Graph Model; 2007 Jan; 25(5):585-94. PubMed ID: 16762573
[TBL] [Abstract][Full Text] [Related]
11. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
12. Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease.
Lin CW; Huang HD; Shiu SY; Chen WJ; Tsai MH; Huang SH; Wan L; Lin YJ
Virus Res; 2007 Jul; 127(1):88-94. PubMed ID: 17467838
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the nucleoside triphosphatase, RNA triphosphatase, and unwinding activities of the helicase domain of dengue virus NS3 protein.
Wang CC; Huang ZS; Chiang PL; Chen CT; Wu HN
FEBS Lett; 2009 Feb; 583(4):691-6. PubMed ID: 19166847
[TBL] [Abstract][Full Text] [Related]
14. The active essential CFNS3d protein complex.
Melino S; Fucito S; Campagna A; Wrubl F; Gamarnik A; Cicero DO; Paci M
FEBS J; 2006 Aug; 273(16):3650-62. PubMed ID: 16911516
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
[TBL] [Abstract][Full Text] [Related]
16. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
[TBL] [Abstract][Full Text] [Related]
18. Structure-based mutational analysis of the NS3 helicase from dengue virus.
Sampath A; Xu T; Chao A; Luo D; Lescar J; Vasudevan SG
J Virol; 2006 Jul; 80(13):6686-90. PubMed ID: 16775356
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the NS2B/NS3 protease complex from seven viruses belonging to different groups inside the genus Flavivirus.
Bessaud M; Pastorino BA; Peyrefitte CN; Rolland D; Grandadam M; Tolou HJ
Virus Res; 2006 Sep; 120(1-2):79-90. PubMed ID: 16504332
[TBL] [Abstract][Full Text] [Related]
20. A Proline-Rich N-Terminal Region of the Dengue Virus NS3 Is Crucial for Infectious Particle Production.
Gebhard LG; Iglesias NG; Byk LA; Filomatori CV; De Maio FA; Gamarnik AV
J Virol; 2016 Jun; 90(11):5451-61. PubMed ID: 27009958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
